Marie Washburn
Fortune : 70 822 $ au 31/07/2026
Fortune : 70 822 $ au 31/07/2026
Marie Washburn currently works at Longeveron, Inc., as Senior VP, Chief Financial & Accounting Officer from 2026.
Ms. Washburn also formerly worked at Fore Biotherapeutics, Inc., as Vice President-Finance in 2025.
Ms. Washburn received her undergraduate degree in 1997 from Bryant University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LONGEVERON INC. CLASS A 0,34 % | 13/07/2026 | 101 030 ( 0,34 % ) | 70 822 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LONGEVERON INC. | Directeur Financier/CFO | 13/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Directeur Financier/CFO | 01/06/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Bryant University
Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
Longeveron, Inc.
Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national